Norges Bank’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-43,816
Closed -$1.18M 1508
2025
Q2
$1.18M Sell
43,816
-56,685
-56% -$1.64M ﹤0.01% 1515
2025
Q1
$2.98M Sell
100,501
-125,101
-55% -$4.77M ﹤0.01% 1455
2024
Q4
$8.93M Buy
225,602
+37,647
+20% +$1.43M ﹤0.01% 1377
2024
Q3
$6.4M Buy
187,955
+31,553
+20% +$888K ﹤0.01% 1457
2024
Q2
$3.39M Sell
156,402
-167,530
-52% -$3.52M ﹤0.01% 1629
2024
Q1
$7.18M Sell
323,932
-82,817
-20% -$2.02M ﹤0.01% 1544
2023
Q4
$11.2M Sell
406,749
-55,391
-12% -$1.34M ﹤0.01% 1443
2023
Q3
$10.3M Buy
462,140
+258,157
+127% +$6.64M ﹤0.01% 1459
2023
Q2
$5.2M Sell
203,983
-280,300
-58% -$6.79M ﹤0.01% 1710
2023
Q1
$10.8M Buy
484,283
+105,455
+28% +$2.55M ﹤0.01% 1553
2022
Q4
$8.99M Buy
378,828
+65,123
+21% +$1.51M ﹤0.01% 1607
2022
Q3
$5.21M Sell
313,705
-159,094
-34% -$3.58M ﹤0.01% 1751
2022
Q2
$9.41M Sell
472,799
-36,202
-7% -$731K ﹤0.01% 1580
2022
Q1
$14M Buy
509,001
+186,200
+58% +$5.33M ﹤0.01% 1568
2021
Q4
$13.3M Sell
322,801
-162,200
-33% -$7.17M ﹤0.01% 1656
2021
Q3
$22.5M Sell
485,001
-63,518
-12% -$2.77M 0.01% 1416
2021
Q2
$21.9M Buy
548,519
+4,060
+0.7% +$174K ﹤0.01% 1483
2021
Q1
$29.3M Buy
544,459
+518,453
+1,994% +$29.9M 0.01% 1306
2020
Q4
$1.27M Buy
+26,006
New +$1.21M ﹤0.01% 2004
2020
Q1
Sell
-40,000
Closed -$1.12M 2073
2019
Q4
$1.12M Hold
40,000
﹤0.01% 2017
2019
Q3
$960K Hold
40,000
﹤0.01% 2038
2019
Q2
$1.14M Buy
+40,000
New +$999K ﹤0.01% 2029

Other funds holding VCYT

Norges Bank's VCYT Position: Q3 2025 in Review

Norges Bank sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 43,816 shares — an estimated $1.18M sold.

Norges Bank first reported a position in VCYT in Q2 2019 and held it in 22 quarters. The position peaked at $29.3M in Q1 2021. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Norges Bank reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Norges Bank sold 43,816 Veracyte shares in Q3 2025, an estimated $1.18M.
  • Norges Bank first reported a position in Veracyte in Q2 2019 and held it in 22 quarters.
  • Norges Bank's Veracyte position peaked at $29.3M in Q1 2021.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.